This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Genetics Institute, LLC
Genetics Institute, LLC, a leading player in the biotechnology sector, is headquartered in the United States and operates across major regions including North America and Europe. Founded in 2005, the institute has made significant strides in genetic research and personalised medicine, establishing itself as a pioneer in the field. The company specialises in advanced genomic sequencing and analysis, offering unique services that cater to both clinical and research applications. Its innovative approach to genetic testing and data interpretation sets it apart from competitors, ensuring high accuracy and reliability. With a strong market position, Genetics Institute, LLC has achieved notable milestones, including partnerships with renowned research institutions and contributions to groundbreaking studies in genomics. The institute continues to drive advancements in genetic technology, making a lasting impact on healthcare and scientific research.
DitchCarbon Score
How does Genetics Institute, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Genetics Institute, LLC's score of 84 is higher than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Genetics Institute, LLC, headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Pfizer Inc., which means that any relevant emissions data or climate commitments may be inherited from its parent organisation. As part of its corporate family relationship with Pfizer Inc., Genetics Institute, LLC aligns with the climate initiatives and targets set by Pfizer. This includes commitments to the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and the RE100 initiative, all of which are cascaded from Pfizer Inc. at a first-level relationship. However, specific reduction targets or achievements for Genetics Institute, LLC have not been detailed. While no direct emissions data is available, the overarching commitment to sustainability and climate action is evident through its affiliation with Pfizer, which actively engages in reducing its carbon footprint and addressing climate change.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | - | - | - | - | - | - | 000,000,000 | 000,000,000 | - | - | - |
| Scope 2 | - | - | - | - | - | - | - | - | 000,000,000 | 000,000,000 | - | - | - |
| Scope 3 | - | - | - | - | - | - | - | 000,000,000 | 0,000,000,000 | 0,000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Genetics Institute, LLC is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
